José Adélaı̈de

11.6k total citations
130 papers, 7.6k citations indexed

About

José Adélaı̈de is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, José Adélaı̈de has authored 130 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 41 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in José Adélaı̈de's work include Cancer Genomics and Diagnostics (26 papers), Genomic variations and chromosomal abnormalities (19 papers) and Acute Myeloid Leukemia Research (12 papers). José Adélaı̈de is often cited by papers focused on Cancer Genomics and Diagnostics (26 papers), Genomic variations and chromosomal abnormalities (19 papers) and Acute Myeloid Leukemia Research (12 papers). José Adélaı̈de collaborates with scholars based in France, United States and Italy. José Adélaı̈de's co-authors include Daniel Birnbaum, Max Chaffanet, François Bertucci, Pascal Finetti, Emmanuelle Charafe‐Jauffret, Jocelyne Jacquemier, Patrice Viens, Christophe Ginestier, Nathalie Cervera and Luc Xerri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

José Adélaı̈de

128 papers receiving 7.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
José Adélaı̈de 4.4k 2.7k 1.9k 956 842 130 7.6k
Pulivarthi H. Rao 4.2k 1.0× 2.5k 0.9× 1.4k 0.8× 1.1k 1.2× 499 0.6× 129 7.7k
Edwin Clark 4.1k 0.9× 2.5k 0.9× 1.7k 0.9× 429 0.4× 913 1.1× 61 8.4k
Adrian Merlo 5.8k 1.3× 2.8k 1.0× 1.9k 1.0× 634 0.7× 280 0.3× 89 9.4k
Jun Yokota 4.6k 1.0× 3.3k 1.2× 2.0k 1.0× 894 0.9× 388 0.5× 140 8.3k
Stefano Indraccolo 3.5k 0.8× 2.5k 0.9× 2.2k 1.1× 526 0.6× 367 0.4× 209 7.0k
Marc‐Henri Stern 3.5k 0.8× 2.4k 0.9× 2.1k 1.1× 635 0.7× 297 0.4× 149 6.5k
Bryan D. Young 5.2k 1.2× 1.6k 0.6× 1.6k 0.8× 1.5k 1.6× 1.9k 2.2× 191 9.2k
C M Croce 5.2k 1.2× 2.4k 0.9× 1.3k 0.7× 1.4k 1.4× 1.3k 1.5× 102 8.8k
Richard A. Ashmun 5.9k 1.3× 4.5k 1.6× 917 0.5× 811 0.8× 598 0.7× 53 8.4k
A. Malcolm R. Taylor 7.7k 1.7× 3.5k 1.3× 2.7k 1.4× 1.3k 1.4× 303 0.4× 132 9.9k

Countries citing papers authored by José Adélaı̈de

Since Specialization
Citations

This map shows the geographic impact of José Adélaı̈de's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Adélaı̈de with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Adélaı̈de more than expected).

Fields of papers citing papers by José Adélaı̈de

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Adélaı̈de. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Adélaı̈de. The network helps show where José Adélaı̈de may publish in the future.

Co-authorship network of co-authors of José Adélaı̈de

This figure shows the co-authorship network connecting the top 25 collaborators of José Adélaı̈de. A scholar is included among the top collaborators of José Adélaı̈de based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Adélaı̈de. José Adélaı̈de is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nonneville, Alexandre de, Elsa Kalbacher, Arnaud Guillé, et al.. (2024). Endometrioid ovarian carcinoma landscape: pathological and molecular characterization. Molecular Oncology. 18(10). 2586–2600. 1 indexed citations
2.
Guillé, Arnaud, José Adélaı̈de, Raoudha Doghri, et al.. (2024). Decoding the pathological and genomic profile of epithelial ovarian cancer. Scientific Reports. 14(1). 28573–28573. 1 indexed citations
3.
Lefeuvre‐Plesse, Claudia, Alejandra Martínez, Céline Chauleur, et al.. (2023). Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network. Journal of Translational Medicine. 21(1). 408–408. 6 indexed citations
4.
Cervera, Nathalie, Arnaud Guillé, José Adélaı̈de, et al.. (2023). Erythroleukemia: Classification. SHILAP Revista de lepidopterología. 4(2). 450–453. 6 indexed citations
5.
Adélaı̈de, José, Thi Khanh Le, Pascal Finetti, et al.. (2023). ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines. Pharmaceutics. 15(7). 1930–1930. 3 indexed citations
6.
Dion, Camille, David Hirst, Leslie Caron, et al.. (2023). In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype. Nucleic Acids Research. 51(14). 7269–7287. 3 indexed citations
7.
Nonneville, Alexandre de, Sébastien Salas, François Bertucci, et al.. (2022). TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. EMBO Molecular Medicine. 14(10). e15859–e15859. 27 indexed citations
8.
Sabatier, Renaud, Cécile Vicier, Séverine Garnier, et al.. (2022). Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular Oncology. 16(10). 2057–2070. 5 indexed citations
9.
Guillé, Arnaud, Pierre‐Emmanuel Colombo, José Adélaı̈de, et al.. (2022). Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of Personalized Medicine. 12(5). 655–655. 2 indexed citations
10.
Finetti, Pascal, Arnaud Guillé, José Adélaı̈de, et al.. (2014). ESPL1 is a candidate oncogene of luminal B breast cancers. Breast Cancer Research and Treatment. 147(1). 51–59. 41 indexed citations
11.
Sircoulomb, Fabrice, Ismahane Bekhouche, Pascal Finetti, et al.. (2010). Genome profiling of ERBB2-amplified breast cancers. BMC Cancer. 10(1). 539–539. 123 indexed citations
12.
Adélaı̈de, José, Pascal Finetti, Ismahane Bekhouche, et al.. (2007). Integrated Profiling of Basal and Luminal Breast Cancers. Cancer Research. 67(24). 11565–11575. 221 indexed citations
13.
Lassailly, François, Julien Mozziconacci, Tetsuro Noguchi, et al.. (2007). Comparison of a Selection of Rapid Automated DNA and RNA Extraction Technologies for Detection of Somatic or Constitutional Gene Abnormalities in Cancer Diagnosis. 5(1). 2–15. 3 indexed citations
14.
Bertucci, François, Pascal Finetti, Nathalie Cervera, et al.. (2006). Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers. Cancer Research. 66(9). 4636–4644. 218 indexed citations
15.
Ginestier, Christophe, Nathalie Cervera, Pascal Finetti, et al.. (2006). Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers. Clinical Cancer Research. 12(15). 4533–4544. 107 indexed citations
16.
Jacquemier, Jocelyne, Christophe Ginestier, Jacques Rougemont, et al.. (2005). Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis. Cancer Research. 65(3). 767–779. 174 indexed citations
17.
Charafe‐Jauffret, Emmanuelle, Christophe Ginestier, F. Monville, et al.. (2005). Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene. 25(15). 2273–2284. 444 indexed citations
18.
Chin, Suet‐Feung, Christophe Ginestier, Valérie‐Jeanne Bardou, et al.. (2004). A Recurrent Chromosome Breakpoint in Breast Cancer at the NRG1 / Neuregulin 1 / Heregulin Gene. Cancer Research. 64(19). 6840–6844. 73 indexed citations
19.
Jacquemier, J, F Penault–Llorca, Patrice Viens, et al.. (1995). Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expression.. PubMed. 14(6B). 2773–8. 37 indexed citations
20.
Penault‐Llorca, Frédérique, José Adélaı̈de, Gilles Houvenaeghel, et al.. (1994). Optimization of immunohistochemical detection of ERBB2 in human breast cancer: Impact of fixation. The Journal of Pathology. 173(1). 65–75. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pulivarthi H. Rao Breakdown of academic impact, for papers by Edwin Clark Breakdown of academic impact, for papers by Adrian Merlo Breakdown of academic impact, for papers by Jun Yokota Breakdown of academic impact, for papers by Stefano Indraccolo Breakdown of academic impact, for papers by Marc‐Henri Stern Breakdown of academic impact, for papers by Bryan D. Young Breakdown of academic impact, for papers by C M Croce Breakdown of academic impact, for papers by Richard A. Ashmun Breakdown of academic impact, for papers by A. Malcolm R. Taylor
Rankless by CCL
2026